We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$60.5M
AUM Growth
-$19.9M
Cap. Flow
-$41.8M
Cap. Flow %
-69.1%
Top 10 Hldgs %
84.49%
Holding
67
New
15
Increased
Reduced
12
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 33.08%
2 Consumer Discretionary 10.33%
3 Communication Services 6.4%
4 Materials 2.51%
5 Technology 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGLBW
26
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$66K 0.11%
214,500
PLXP
27
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$56K 0.09%
13,878
-15,404
-53% -$57.9K
MDGSW
28
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$47K 0.08%
+64,286
New +$38.2K
RCON icon
29
Recon Technology
RCON
$32.6M
$44K 0.07%
396
-3,544
-90% -$435K
SOLOW
30
DELISTED
Electrameccanica Vehicles Corp. Ltd. Warrants
SOLOW
$36K 0.06%
+96,000
New +$49K
APOPW
31
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$23K 0.04%
12,570
AMRHW
32
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$23K 0.04%
125,503
IMRNW
33
DELISTED
Immuron Limited Warrants
IMRNW
$22K 0.04%
10,941
-4,100
-27% -$14.8K
SNGXW
34
DELISTED
Soligenix, Inc. Warrant
SNGXW
$21K 0.03%
61,000
ONTXW
35
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$17K 0.03%
170,000
-3,112
-2% -$498
FPAYW
36
DELISTED
FlexShopper, Inc. Warrants
FPAYW
$12K 0.02%
+50,000
New +$13.3K
APDNW
37
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$7K 0.01%
31,407
BNTCW
38
DELISTED
Benitec Biopharma Limited
BNTCW
$6K 0.01%
50,000
MYNDW
39
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$3K 0.01%
13,700
CYTXZ
40
DELISTED
Cytori Therapeutics Inc Series S Warrant
CYTXZ
$1K ﹤0.01%
259,200
CRDF icon
41
Cardiff Oncology
CRDF
$66.2M
-51,241
Closed -$237K
CVM icon
42
CEL-SCI Corp
CVM
$21.3M
-26,700
Closed -$737K
GLMD icon
43
Galmed Pharmaceuticals
GLMD
$4.95M
-83
Closed -$177K
KURA icon
44
Kura Oncology
KURA
$826M
-76,200
Closed -$1.39M
LMNR icon
45
Limoneira
LMNR
$241M
-25,946
Closed -$639K
NUWE icon
46
Nuwellis
NUWE
$410K
0
-$640K
NVAX icon
47
Novavax
NVAX
$1.22B
-165,780
Closed -$4.44M
QUIK icon
48
QuickLogic
QUIK
$228M
-4,146
Closed -$67K
RKDA icon
49
Arcadia Biosciences
RKDA
$1.38M
-2,986
Closed -$984K
SCYX icon
50
SCYNEXIS
SCYX
$37M
-2,957
Closed -$388K

Similar funds

CVI Holdings's Q3 2018 Portfolio in Review

As of Q3 2018, CVI Holdings held 67 positions worth $60.5M, down 25% from $80.3M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

CVI Holdings withdrew a net $41.8M in Q3 2018, closing 20 positions and reducing 12 holdings. Its most notable exit was Novavax, an estimated $4.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, CVI Holdings opened a new position in Bombardier Recreational Products worth $6.25M.

  • CVI Holdings's largest Q3 2018 buy was Bombardier Recreational Products: 133,226 shares worth $6.25M.
  • CVI Holdings's biggest Q3 2018 reduction was Eros Media World PLC, cutting an estimated $10.9M.
  • CVI Holdings fully exited Novavax in Q3 2018, selling an estimated $4.44M.
  • CVI Holdings's ten largest holdings make up 84% of its $60.5M portfolio in Q3 2018.
  • CVI Holdings opened 15 new positions and closed 20 in Q3 2018.
  • CVI Holdings's portfolio value fell 25% quarter-over-quarter to $60.5M.

Based on CVI Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.